Brennan Aoife insider trades

Brennan Aoife has filed 15 Form 4s with the SEC that we hold, for Climb Bio, Inc. (CLYM) (President and CEO, Director), Synlogic, INC. (SYBX) (President and CEO, Director), Kyntra Bio, INC. (FGEN) (Director) and Xilio Therapeutics, Inc. (XLO) (Director). Across all of them we count 0 purchases worth $0 and 6 sales worth $546.3K reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($407.0K). The largest single trade was a sale of 30,902 shares of Climb Bio, Inc. worth $407.0K, dated 2026-06-29. The first filing on our record is dated 2022-02-08 and the latest 2026-06-30.

Climb Bio, Inc. (CLYM)

President and CEO, Director · 5 filings · 2 purchases and sales

Trade date	Code	Shares	Value as filed	Filed	Source
2025-06-30	S, sale reported on Form 4	20,618	$25.2K	2025-07-01	SEC
2026-06-29	S, sale reported on Form 4	30,902	$407.0K	2026-06-30	SEC

Synlogic, INC. (SYBX)

President and CEO, Director · 4 filings · 2 purchases and sales

Trade date	Code	Shares	Value as filed	Filed	Source
2022-04-04	S, sale reported on Form 4	8,894	$21.8K	2022-04-06	SEC
2023-04-03	S, sale reported on Form 4	19,042	$11.0K	2023-04-05	SEC

Kyntra Bio, INC. (FGEN)

Director · 3 filings · 2 purchases and sales

Trade date	Code	Shares	Value as filed	Filed	Source
2023-06-09	S, sale reported on Form 4	2,739	$48.0K	2023-06-09	SEC
2023-06-09	S, sale reported on Form 4	1,994	$33.4K	2023-06-09	SEC

Xilio Therapeutics, Inc. (XLO)

Director · 3 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1714563) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-28 · For informational purposes only, not investment advice.
Privacy · Terms